Evidence map›Paper›PMID 38920304›Full record

ArticleACS applied materials & interfaces2024

Coupling Peptide-Based Encapsulation of Enzymes with Bacteria for Paraoxon Bioremediation.

Yoav Dan, David Gurevich, Ofir Gershoni, Francesca Netti, Lihi Adler-Abramovich, Livnat Afriat-Jurnou

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yoav DanDepartment of Oral Biology, The Goldschleger School of Dental Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0002-3683-0474
David GurevichMigal-Galilee Research Institute, Kiryat Shmona 11016, Israel.
Ofir GershoniMigal-Galilee Research Institute, Kiryat Shmona 11016, Israel.
Francesca NettiDepartment of Oral Biology, The Goldschleger School of Dental Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
Lihi Adler-AbramovichDepartment of Oral Biology, The Goldschleger School of Dental Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0003-3433-0625
Livnat Afriat-JurnouMigal-Galilee Research Institute, Kiryat Shmona 11016, Israel.ORCID 0000-0002-4821-0328

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The catalytic efficiency of enzymes can be harnessed as an environmentally friendly solution for decontaminating various xenobiotics and toxins. However, for some xenobiotics, several enzymatic steps are needed to obtain nontoxic products. Another challenge is the low durability and stability of many native enzymes in their purified form. Herein, we coupled peptide-based encapsulation of bacterial phosphotriesterase with soil-originated bacteria,

Indexed as

Biodegradation, EnvironmentalParaoxonPhosphoric Triester HydrolasesArthrobacterBacterial ProteinsEnzymes, ImmobilizedHydrolysisNitrophenolsPeptidesPesticides4-nitrophenolBacterial ProteinsEnzymes, ImmobilizedNitrophenolsParaoxonPeptidesPesticidesPhosphoric Triester Hydrolasesbioremediationenzyme encapsulationnanostructuresone-pot systemorganophosphatesphosphotriesterase

Identifiers

PMID38920304
PMCPMC11247427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.